These findings suggest that LKB1 loss suppresses DPP4 expression, contributing to the immunosuppressive characteristics of the TME in KL-NSCLC cells, whereas restoring DPP4 expression promotes NK-cell recruitment, facilitates immune activation, and enhances the effects of anti–PD-1 therapy. Here, STK11 is linked to non-small cell lung carcinoma.